SCM Lifescience Co., Ltd. (KOSDAQ: 298060)

SCM Lifescience Revenue

SCM Lifescience had revenue of 170.43M KRW in the quarter ending September 30, 2024, a decrease of -40.11%. This brings the company's revenue in the last twelve months to 889.44M, up 59.52% year-over-year. In the year 2023, SCM Lifescience had annual revenue of 695.70M with 75.69% growth.

• Revenue (ttm): 889.44M
• Revenue Growth: +59.52%
• P/S Ratio: 44.86
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 39.87B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	695.70M	299.72M	75.69%
Dec 31, 2022	395.98M	-43.28M	-9.85%
Dec 31, 2021	439.26M	119.26M	37.27%
Dec 31, 2020	320.01M	151.51M	89.92%
Dec 31, 2019	168.50M	139.74M	485.85%